| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +10.33% | +4.14% | +6.19% | +6.19% | — |
| 14d | 1 | +0.00% | +23.69% | +7.24% | +16.45% | +16.45% | — |
| 30d | 1 | +0.00% | +8.90% | +4.79% | +4.11% | +4.11% | — |
| 60d | 1 | +100.00% | -22.42% | +1.70% | -24.11% | -24.11% | — |
| 90d | 1 | +100.00% | -29.25% | +6.97% | -36.22% | -36.22% | — |
| 180d | 1 | +0.00% | +9.86% | +17.75% | -7.89% | -7.89% | — |
| 1y | 1 | +100.00% | -18.60% | +26.02% | -44.62% | -44.62% | — |
| 2y | 1 | +100.00% | -75.68% | +58.10% | -133.78% | -133.78% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 61,963 | — | — | 407,874 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 93,037 | — | — | 93,037 | Feb 11, 2026 | Feb 13, 2026 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 283,018 | — | — | 283,018 | Oct 6, 2025 | Oct 8, 2025 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 62,893 | — | — | 345,911 | Oct 6, 2025 | Oct 8, 2025 ↗ | View → |
| RCKT ROCKET PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 383,854 | — | — | 383,854 | Oct 6, 2025 | Oct 8, 2025 ↗ | View → |
| CRBU CARIBOU BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 131,000 | — | — | 131,000 | Feb 21, 2023 | Feb 23, 2023 ↗ | View → |
| CRBU CARIBOU BIOSCIENCES, INC. | SALE Chief Medical Officer | 5,627 | $6.31 | $35.5K | 59,373 | Jan 19, 2023 | Jan 20, 2023 ↗ | View → |
| CRBU CARIBOU BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 161,250 | — | — | 161,250 | Jan 25, 2022 | Jan 25, 2022 ↗ | View → |
| CRBU CARIBOU BIOSCIENCES, INC. | PURCHASEGRANT Stock grant | 60,000 | — | — | 65,000 | Jan 25, 2022 | Jan 25, 2022 ↗ | View → |